Becker's Healthcare January 11, 2019
From 1995 to 2015, the change in inflation-adjusted dollars spent on treating six of the top seven patient conditions associated with the highest mortality and morbidity rates in the U.S. likely was cost-effective and created value, according to a study published in Health Affairs.
Five things to know:
1. For the study, researchers with RTI Health Solutions in Durham, N.C., and the National Pharmaceutical Council examined whether medical intervention spending on seven chronic conditions during the past two decades has been a good investment. The study authors analyzed national-level data from the CDC, the Global Burden of Disease Study and the Medical Expenditure Panel Survey.
2. Researchers found after accounting for the prevalence of each disease and controlling for inflation,...
Today's Sponsors
Today's Sponsor